3-(4-methoxyphenyl)-6-(thiophen-3-yl)pyrazolo[1,5-a]pyrimidine

ID: ALA4082186

Chembl Id: CHEMBL4082186

PubChem CID: 137645774

Max Phase: Preclinical

Molecular Formula: C17H13N3OS

Molecular Weight: 307.38

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(-c2cnn3cc(-c4ccsc4)cnc23)cc1

Standard InChI:  InChI=1S/C17H13N3OS/c1-21-15-4-2-12(3-5-15)16-9-19-20-10-14(8-18-17(16)20)13-6-7-22-11-13/h2-11H,1H3

Standard InChI Key:  LNYOFLOPBUAZGE-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4082186

    ---

Associated Targets(Human)

KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDGFRB Tclin VEGF-receptor 2 and PDGF-receptor beta (KDR and PDGFR beta) (29 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 307.38Molecular Weight (Monoisotopic): 307.0779AlogP: 4.13#Rotatable Bonds: 3
Polar Surface Area: 39.42Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 0.99CX LogP: 3.57CX LogD: 3.57
Aromatic Rings: 4Heavy Atoms: 22QED Weighted: 0.57Np Likeness Score: -1.90

References

1. Cherukupalli S, Karpoormath R, Chandrasekaran B, Hampannavar GA, Thapliyal N, Palakollu VN..  (2017)  An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold.,  126  [PMID:27894044] [10.1016/j.ejmech.2016.11.019]

Source